EAAT Antibodies

Santa Cruz Biotechnology features a diverse variety of EAAT Antibodies for investigating excitatory amino acid transporters. EAAT Antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Excitatory amino acid transporters play a critical role in regulating synaptic transmission and maintaining glutamate homeostasis in the central nervous system. By controlling extracellular levels of glutamate, EAATs are essential for preventing excitotoxicity, which can lead to neurodegenerative diseases. Understanding the function and regulation of EAATs is crucial for developing therapeutic strategies for conditions such as epilepsy, Alzheimer's disease, and other neurological disorders. EAAT research continues to reveal new insights into neurotransmitter regulation and cellular communication pathways. Investigating EAAT expression patterns helps identify potential therapeutic targets in neurological conditions. Advanced research techniques using monoclonal antibodies enable detailed analysis of EAAT localization and function. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing neuroscience and contributing to the development of new therapeutic approaches for neurological disorders.